InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,334.40
(
0.00%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.02
(
-0.41%
)
Bitcoin
63,574.90
(
0.99%
)
Post# of 12924
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

growacet

Send PM Follow Ignore
Followers 29
Posts 3997
Boards Moderated 0
Alias Born 10/16/2003

growacet

Re: None

Wednesday, 09/05/2018 12:09:15 AM

Wednesday, September 05, 2018 12:09:15 AM

Post# of 12924
Resverlogix's Apabetalone presented at Chinese Conference on Alzheimer's

https://finance.yahoo.com/news/resverlogix-presents-clinical-trials-alzheimer-120000667.html

Resverlogix Corp. (“Resverlogix” or the “Company”) (RVX:TSX) announced today that it has presented at the first Clinical Trials in Alzheimer’s Disease (CTAD) Asia conference in Shanghai, China, this past weekend. Dr. Jeffrey Cummings, Founding Director of the Cleveland Clinic Lou Ruvo Brain Health Center

Listed on Canada's big board TSX symbol RVX.TO no listing yet in the US so it trades OTC symbol RVXCF

If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up